UK Triptan Switch Considered As MHRA Seeks Comment On Imitrex, Zomig

UK consumers seeking a triptan for migraine treatment will be questioned by a pharmacist on their history of cardiovascular and cerebrovascular disease prior to purchase if sumatriptan or zolmitriptan are approved for nonprescription sale in the country

More from Europe

More from Geography